Therapeutic Vasoactive Intestinal Peptide

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Therapeutic Hormone -> Therapeutic Vasoactive Intestinal Peptide

Therapeutic Vasoactive Intestinal Peptide Definition

A recombinant 28-amino-acid neuropeptide that is chemically identical or similar to the endogenous vasoactive intestinal peptide (VIP), with anti-inflammatory and anti-arthritic activities. This agent exerts a wide spectrum of anti-inflammatory activity by inhibiting macrophage functions, including phagocytosis, respiratory burst, and chemotaxis, and also by inhibiting T cell proliferation and decreasing lymphocyte migration. VIP has also been reported to inhibit the production of pro-inflammatory cytokines such as TNF alpha, interferon-gamma, IL-6, IL-12, to reduce the activity of inducible nitric oxide synthase and to enhance the production of the anti-inflammatory cytokines IL-10 and IL-1Ra. This agent exerts its anti-arthritic activity by reducing the titers of autoreactive antibodies against type II collagen (CII), a major factor in determining susceptibility to collagen-induced arthritis (CIA).

Therapeutic Vasoactive Intestinal Peptide Synonyms

Therapeutic Vasoactive Intestinal Peptide, Therapeutic VIP, Therapeutic Vasoactive Intestinal Polypeptide, Vasoactive Intestinal Polypeptide

Terms in Therapeutic Vasoactive Intestinal Peptide category

---

Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.